Perrigo Company PublicCompany Share Price (NYSE: PRGO)

$24.48

▲

1.05

(4.48%)

Last updated on August 23, 2025 at 1:29 AM IST

$₹

Check the interactive Perrigo Company PublicCompany Stock chart to analyse performance

Perrigo Company PublicCompany stock performance

as on August 23, 2025 at 1:29 AM IST

Today's Low:$23.78
Today's High:$24.59
$24.48
2.86%
Downside
Day's Volatility :3.27%
Upside
0.43%
52 Weeks Low:$21.03
52 Weeks High:$30.93
$24.48
14.09%
Downside
52 Weeks Volatility :32.01%
Upside
20.85%

Perrigo Company PublicCompany Stock Returns

Period	Perrigo Company Public Limited Company	Sector (Health Care)	Index (Russel 2000)
3 Months	-10.41%	6.0%	0.0%
6 Months	-2.99%	-5.6%	0.0%
1 Year	-16.2%	-11.1%	0.0%
3 Years	-39.23%	6.8%	-7.8%

Perrigo Company Public Limited Company Key Stats

Check Perrigo Company PublicCompany key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$23.43
Open	$23.78
Today's High	$24.585
Today's Low	$23.78
Market Capitalization	$3.2B
Today's Volume	$2.5M
52 Week High	$30.93
52 Week Low	$21.03
Revenue TTM	$4.3B
EBITDA	$863.8M
Earnings Per Share (EPS)	$-0.43
Dividend Yield	4.84%
Profit Margin	-1.85%
Quarterly Earnings Growth YOY	-0.64%
Return On Equity TTM	-1.32%

Stock Returns calculator for Perrigo Company PublicCompany Stock including INR - Dollar returns

The Perrigo Company PublicCompany stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Perrigo Company PublicCompany investment value today

Current value as on today

₹88,008

Returns

₹11,992

(-11.99%)

Returns from Perrigo Company PublicCompany Stock

₹16,308 (-16.31%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Perrigo Company PublicCompany Stock

491%

Period: Jul 24, 2025 to Aug 23, 2025. Change in 30 Days versus previous period

Search interest for Perrigo Company PublicCompany Stock from India on INDmoney has increased by 491% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Perrigo Company Public Limited Company

Name
Holdings %
Name
Holdings %
T. Rowe Price Associates, Inc.
10.58%
Vanguard Group Inc
10.19%
BlackRock Inc
9.50%
Dimensional Fund Advisors, Inc.
5.46%
State Street Corp
4.87%
DePrince Race & Zollo Inc
3.32%

Analyst Recommendation on Perrigo Company PublicCompany Stock

Rating

Trend

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Perrigo Company PublicCompany(by analysts ranked 0 to 5 stars)

Perrigo Company PublicCompany Share Price Target

What analysts predicted

Upside of 39.91%

Target:

$34.25

Current:

$24.48

Perrigo Company PublicCompany share price target is $34.25, a slight Upside of 39.91% compared to current price of $24.48 as per analysts' prediction.

Perrigo Company PublicCompany Stock Insights

Price Movement
In the last 7 days, PRGO stock has moved up by 7.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.04B → 1.05B (in $), with an average increase of 1.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -6.4M → -8.4M (in $), with an average decrease of 31.3% per quarter
PRGO vs HLN (1 yr)
In the last 1 year, Perrigo Company Public Limited Company has experienced a drawdown of -16.3%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 15.4%
PRGO vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 53.8% return, outperforming this stock by 92.0%
Price to Sales
ForPRGO every $1 of sales, investors are willing to pay $0.8, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Perrigo Company Public Limited Company Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$4.8B	↑ 2.23%
Net Income	$146.1M	↑ 11.53%
Net Profit Margin	3.02%	↑ 0.25%

	FY20	Y/Y Change
Revenue	$5.1B	↑ 4.67%
Net Income	$-162.6M	↓ 211.29%
Net Profit Margin	-3.21%	↓ 6.23%

	FY21	Y/Y Change
Revenue	$4.1B	↓ 18.26%
Net Income	$-130.9M	↓ 19.5%
Net Profit Margin	-3.16%	↑ 0.05%

	FY22	Y/Y Change
Revenue	$4.5B	↑ 7.56%
Net Income	$-130.9M	↑ 0.0%
Net Profit Margin	-2.94%	↑ 0.22%

	FY23	Y/Y Change
Revenue	$4.7B	↑ 4.58%
Net Income	$-12.7M	↓ 90.3%
Net Profit Margin	-0.27%	↑ 2.67%

	FY24	Y/Y Change
Revenue	$4.4B	↓ 6.06%
Net Income	$-171.8M	↑ 1252.76%
Net Profit Margin	-3.93%	↓ 3.66%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.1B	↓ 6.47%
Net Income	$2.0M	↓ 106.19%
Net Profit Margin	0.18%	↑ 2.97%

	Q2 FY24	Q/Q Change
Revenue	$1.1B	↓ 1.53%
Net Income	$-108.4M	↓ 5520.0%
Net Profit Margin	-10.17%	↓ 10.35%

	Q3 FY24	Q/Q Change
Revenue	$1.1B	↑ 2.06%
Net Income	$-21.0M	↓ 80.63%
Net Profit Margin	-1.93%	↑ 8.24%

	Q4 FY24	Q/Q Change
Revenue	$1.1B	↑ 4.67%
Net Income	$-44.5M	↑ 111.9%
Net Profit Margin	-3.91%	↓ 1.98%

	Q1 FY25	Q/Q Change
Revenue	$1.0B	↓ 8.29%
Net Income	$-6.4M	↓ 85.62%
Net Profit Margin	-0.61%	↑ 3.3%

	Q2 FY25	Q/Q Change
Revenue	$1.1B	↑ 1.19%
Net Income	$-8.4M	↑ 31.25%
Net Profit Margin	-0.8%	↓ 0.19%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$1.8B	↓ 3.18%

	FY20	Y/Y Change
Profit	$1.8B	↑ 2.36%

	FY21	Y/Y Change
Profit	$1.4B	↓ 21.98%

	FY22	Y/Y Change
Profit	$1.5B	↑ 2.77%

	FY23	Y/Y Change
Profit	$1.7B	↑ 15.46%

	FY24	Y/Y Change
Profit	$1.5B	↓ 8.19%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$357.7M	↓ 16.29%

	Q2 FY24	Q/Q Change
Profit	$394.7M	↑ 10.34%

	Q3 FY24	Q/Q Change
Profit	$404.4M	↑ 2.46%

	Q4 FY24	Q/Q Change
Profit	$385.9M	↓ 4.57%

	Q1 FY25	Q/Q Change
Profit	$392.3M	↑ 1.66%

	Q2 FY25	Q/Q Change
Profit	$362.9M	↓ 7.49%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$387.8M	↓ 34.6%
Investing Cash Flow	$-596.1M	↑ 370.11%
Financing Cash Flow	$1.8M	↓ 100.31%

	FY20	Y/Y Change
Operating Cash Flow	$636.2M	↑ 64.05%
Investing Cash Flow	$-187.8M	↓ 68.5%
Financing Cash Flow	$-181.1M	↓ 10161.11%

	FY21	Y/Y Change
Operating Cash Flow	$156.3M	↓ 75.43%
Investing Cash Flow	$1.3B	↓ 779.34%
Financing Cash Flow	$-178.7M	↓ 1.33%

	FY22	Y/Y Change
Operating Cash Flow	$307.3M	↑ 96.61%
Investing Cash Flow	$-2.0B	↓ 253.52%
Financing Cash Flow	$421.6M	↓ 335.93%

	FY23	Y/Y Change
Operating Cash Flow	$405.5M	↑ 31.96%
Investing Cash Flow	$-77.5M	↓ 96.04%
Financing Cash Flow	$-187.2M	↓ 144.4%

	FY24	Y/Y Change
Operating Cash Flow	$362.9M	↓ 10.51%
Investing Cash Flow	$78.8M	↓ 201.68%
Financing Cash Flow	$-611.0M	↑ 226.39%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-1.4M	↓ 100.67%
Investing Cash Flow	$-23.5M	↑ 3.07%
Financing Cash Flow	$-60.4M	↑ 35.43%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$9.5M	↓ 778.57%
Investing Cash Flow	$-73.3M	↑ 211.91%
Financing Cash Flow	$-49.8M	↓ 17.55%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$42.2M	↑ 344.21%
Investing Cash Flow	$212.7M	↓ 390.18%
Financing Cash Flow	$653.3M	↓ 1411.85%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$312.6M	↑ 640.76%
Investing Cash Flow	$-37.1M	↓ 117.44%
Financing Cash Flow	$-1.2B	↓ 276.66%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-64.5M	↓ 120.63%
Investing Cash Flow	$-25.7M	↓ 30.73%
Financing Cash Flow	$-61.8M	↓ 94.65%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$75.9M	↓ 217.67%
Investing Cash Flow	$-3.8M	↓ 85.21%
Financing Cash Flow	$-54.0M	↓ 12.62%

Perrigo Company PublicCompany Technicals Summary

Sell

Neutral

Buy

Perrigo Company PublicCompany is currently in a neutral trading position according to technical analysis indicators.

Perrigo Company Public Limited Company Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Perrigo Company Public Limited Company	-12.9%	-2.99%	-16.2%	-39.23%	-53.32%
Haleon Plc Spon Ads	-0.71%	-3.35%	-0.61%	55.22%	32.39%
United Therapeutics Corporation	2.57%	-12.81%	-9.9%	41.47%	75.65%
Zoetis Inc.	2.93%	-5.28%	-13.76%	-5.41%	-1.26%
Neurocrine Biosciences Inc.	2.41%	13.62%	-11.12%	29.75%	20.28%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Perrigo Company Public Limited Company	2818.0	NA	1.14	2.99	-0.01	0.03	0.05	32.5
Haleon Plc Spon Ads	21.8	21.8	3.15	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	12.18	12.18	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.74	26.74	2.54	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	40.02	40.02	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Perrigo Company Public Limited Company	Buy	$3.2B	-53.32%	2818.0	-1.85%
Haleon Plc Spon Ads	Buy	$44.6B	32.39%	21.8	13.81%
United Therapeutics Corporation	Buy	$14.1B	75.65%	12.18	40.36%
Zoetis Inc.	Buy	$69.0B	-1.26%	26.74	27.83%
Neurocrine Biosciences Inc.	Buy	$13.4B	20.28%	40.02	13.88%

Perrigo Company PublicCompany Dividend announcements

Perrigo Company PublicCompany Dividends September, 2025
In the quarter ending September,2025. Perrigo Company PublicCompany has declared dividend of $0.29

About Perrigo Company Public Limited Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Organization	Perrigo Company PublicCompany
Employees	8379
CEO	Mr. Patrick Lockwood-Taylor
Industry	Health Technology

Key Management of Perrigo Company Public Limited Company

Name	Title
Mr. Patrick Lockwood-Taylor	President, CEO & Director
Mr. Eduardo Guarita Bezerra	Executive VP & CFO
Mr. Ronald C. Janish	Chief Transformation Officer
Ms. Catherine C. B. Schmelter	Consultant
Mr. Roberto Khoury	Executive VP & Chief Commercial Officer
Ms. Abbie Lennox	EVP & Chief Scientific Officer
Mr. Bradley Joseph	Vice President of Global Investor Relations & Corporate Communications
Mr. Charles Atkinson	Executive VP, General Counsel & Secretary
Mr. Robert Willis	Chief Human Resources Officer & Executive VP
Dr. David Ball	EVP and Chief Brand & Digital Officer

Important FAQs about investing in PRGO Stock from India :

What is Perrigo Company PublicCompany share price today?

Perrigo Company PublicCompany share price today is $24.48 as on August 23, 2025 at 1:29 AM IST at the close of the market. Perrigo Company PublicCompany share today touched a day high of $24.59 and a low of $23.78.

What is the 52 week high and 52 week low for Perrigo Company PublicCompany share?

Perrigo Company PublicCompany share touched a 52 week high of $30.93 and a 52 week low of $21.03. Perrigo Company PublicCompany stock price today i.e. August 23, 2025 at 1:29 AM IST is closed at $24.48, lower by 20.85% versus the 52 week high.

How to invest in Perrigo Company PublicCompany Stock (PRGO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Perrigo Company PublicCompany on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Perrigo Company PublicCompany Shares that will get you 0.0613 shares as per Perrigo Company PublicCompany share price of $24.48 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Perrigo Company PublicCompany Stock (PRGO) from India?

Indian investors can start investing in Perrigo Company PublicCompany (PRGO) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Perrigo Company PublicCompany stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Perrigo Company PublicCompany share’s latest price of $24.48 as on August 23, 2025 at 1:29 AM IST, you will get 0.4085 shares of Perrigo Company PublicCompany. Learn more about fractional shares .

What are the returns that Perrigo Company PublicCompany has given to Indian investors in the last 5 years?

Perrigo Company PublicCompany stock has given -53.32% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?